From: The relationship between myasthenia gravis and COVID-19: a systematic review
No. | Major components | 1 | 2 | 3 | 4 | 5 | 6 |
---|---|---|---|---|---|---|---|
1 | Were there clear criteria for inclusion in the case series? | Y | Y | Y | Y | Y | Y |
2 | Was the condition measured in a standard, reliable way for all participants included in the case series? | Y | Y | Y | Y | Y | Y |
3 | Were valid methods used for identification of the condition for all participants included in the case series? | Y | Y | Y | Y | Y | Y |
4 | Did the case series have consecutive inclusion of participants? | Y | Y | Y | Y | Y | Y |
5 | Did the case series have complete inclusion of participants? | Y | Y | Y | Y | Y | Y |
6 | Was there clear reporting of the demographics of the participants in the study? | Y | Y | Y | Y | Y | Y |
7 | Was there clear reporting of clinical information of the participants? | Y | Y | Y | Y | Y | Y |
8 | Were the outcomes or follow-up results of cases clearly reported? | Y | Y | Y | Y | Y | Y |
9 | Was there clear reporting of the presenting site(s)/clinic(s) demographic information? | Y | Y | Y | Y | Y | Y |
10 | Was statistical analysis appropriate? | NA | NA | NA | NA | NA | NA |
 | Overall appraisal | I | I | I | I | I | I |